ArticleJournal of experimental & clinical cancer research : CR2018

SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.

Jian Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.